February 1, 2018 / 6:09 AM / 4 months ago

BRIEF-Biotec Pharmacon Q4 EBITDA Loss Narrows To NOK ‍​7.2 Million

Feb 1 (Reuters) - BIOTEC PHARMACON ASA:

* Q4 REVENUE NOK 17.7‍​ MILLION VERSUS NOK 18.2 MILLION YEAR AGO

* Q4 EBITDA LOSS NOK ‍​7.2 MILLION VERSUS LOSS NOK 8.1 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below